Palvella Therapeutics (PVLA) Cash from Investing Activities Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 116.52% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 38.24% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -22.09% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 30.54% |
| 10 | Palvella Therapeutics | 1.47 Bn | 1.21 Bn | - | -88.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -88.12% |
| Sep 30, 2024 | 33.99% |
| Jun 30, 2024 | 125.73% |
| Mar 31, 2024 | 586.42% |
| Dec 31, 2023 | -38.53% |
| Sep 30, 2023 | -28.22% |
| Jun 30, 2023 | -30.92% |
| Mar 31, 2023 | 206.35% |
| Dec 31, 2022 | 37.30% |
| Sep 30, 2022 | 9.88% |
| Jun 30, 2022 | -41.64% |
| Mar 31, 2022 | -47.18% |
| Dec 31, 2021 | 59.68% |
| Sep 30, 2021 | -26.13% |
| Jun 30, 2021 | 83.25% |
| Mar 31, 2021 | 85.00% |
| Dec 31, 2020 | 32.61% |
| Sep 30, 2020 | 303.10% |
| Jun 30, 2020 | 118.56% |
| Mar 31, 2020 | 62.78% |
| Dec 31, 2019 | -99.39% |
| Sep 30, 2019 | 183.61% |
| Jun 30, 2019 | 512.49% |
| Mar 31, 2019 | -327.76% |
| Dec 31, 2018 | -145.76% |
| Sep 30, 2018 | 550.98% |
| Jun 30, 2018 | -1,031.76% |
| Mar 31, 2018 | -488.70% |
| Sep 30, 2017 | -172.32% |
| Jun 30, 2017 | -411.27% |
| Mar 31, 2017 | -366.08% |